Post-COVID19 Lung Fibrosis: An Worrying Experience of COVID19 Survivors

Authors

  • SM AA Mamun Senior Consultant of Respiratory Medicine, Evercare Hospitals, Dhaka, Bangladesh
  • Zafor Iqbal Consultant, Intensive care unit, Evercare Hospitals, Dhaka, Bangladesh
  • Arif Mahmood Public health specialist & deputy director of Evercare Hospitals, Dhaka, Bangladesh
  • Sania Ahsan Senior Consultant of Radiology& Imaging, Evercare Hospitals, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/bjm.v33i1.56801

Keywords:

COVID-19, Fibrosis, Antifibrotic.

Abstract

Patients recovering from confirmed COVID19 particularly moderate to severe disease, those treated in HDU / ICU support with high flow nasal cannula & Mechanical ventilation ,experienced different symptoms ranging from tiredness, fatigue to severe exertional dyspnea. High resolution CT scan of Chest of these such patients showed persistent radiological abnormalities simulating progressive fibrotic lung disease. Lung function including CO transfer factor revealed moderate to severe reduction. In case of patients recovered from moderate to severe COVID19 pneumonia, lung fibrosis is a big problem and it is one of the most worrying long-term complications. Lung fibrosis was documented in previous Severe Acute Respiratory Syndrome & Middle east Respiratory Syndrome pathology, and current observational studies suggests that pulmonary fibrosis could also complicate infection by SARSCOV2. The objective of our study was to set up a criteria of patients who are at risk to develop such serious complication, thus giving a chance for early detection of post-COVID19 lung fibrosis and thus preventing such disabling complication by proper andearly intervention .

Bangladesh J Medicine July 2022; 33(1) : 114-119

Downloads

Download data is not yet available.
Abstract
74
PDF
70

Downloads

Published

2021-12-06

How to Cite

Mamun, S. A., Iqbal, Z. ., Mahmood, A., & Ahsan, S. . (2021). Post-COVID19 Lung Fibrosis: An Worrying Experience of COVID19 Survivors. Bangladesh Journal of Medicine, 33(1), 114–119. https://doi.org/10.3329/bjm.v33i1.56801

Issue

Section

Short Communication